Prestige Wealth Management Group’s ResMed RMD Stock Holding History

Prestige Wealth Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.51K	Buy	18 +4	+29%	+$829	﹤0.01%	658
2026 Q1	$3.14K	Hold	14	–	–	﹤0.01%	646
2025 Q4	$3.37K	Hold	14	–	–	﹤0.01%	660
2025 Q3	$3.83K	Hold	14	–	–	﹤0.01%	622
2025 Q2	$3.61K	Hold	14	–	–	﹤0.01%	623
2025 Q1	$3.13K	Hold	14	–	–	﹤0.01%	653
2024 Q4	$3.2K	Hold	14	–	–	﹤0.01%	686
2024 Q3	$3.42K	Hold	14	–	–	﹤0.01%	673
2024 Q2	$2.68K	Hold	14	–	–	﹤0.01%	663
2024 Q1	$2.77K	Hold	14	–	–	﹤0.01%	689
2023 Q4	$2.41K	Buy	14 +6	+75%	+$922	﹤0.01%	716
2023 Q3	$1.18K	Buy	8 +2	+33%	+$362	﹤0.01%	851
2023 Q2	$1.31K	Hold	6	–	–	﹤0.01%	860
2023 Q1	$1.31K	Hold	6	–	–	﹤0.01%	835
2022 Q4	$1.25K	Hold	6	–	–	﹤0.01%	932
2022 Q3	$1K	Hold	6	–	–	﹤0.01%	907
2022 Q2	$1K	Hold	6	–	–	﹤0.01%	911
2022 Q1	$1K	Hold	6	–	–	﹤0.01%	921
2021 Q4	$2K	Hold	6	–	–	﹤0.01%	827
2021 Q3	$2K	Hold	6	–	–	﹤0.01%	820
2021 Q2	$1K	Hold	6	–	–	﹤0.01%	920
2021 Q1	$1K	Sell	6 -3	-33%	-$602	﹤0.01%	907
2020 Q4	$2K	Buy	9 +3	+50%	+$598	﹤0.01%	779
2020 Q3	$1K	Hold	6	–	–	﹤0.01%	830
2020 Q2	$1K	Sell	6 -8	-57%	-$1.31K	﹤0.01%	833
2020 Q1	$2K	Buy	+14	New	+$2.23K	﹤0.01%	665
2019 Q1	–	Sell	-24	Closed	-$3K	–	992
2018 Q4	$3K	Buy	+24	New	+$2.57K	﹤0.01%	747

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prestige Wealth Management Group's RMD Position: Q2 2026 in Review

Prestige Wealth Management Group increased its ResMed (RMD) stake by 29% in Q2 2026, buying an estimated $829 and bringing the position to 18 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Prestige Wealth Management Group first reported a position in RMD in Q4 2018 and has held it in 27 quarters since. The position peaked at $3.83K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Prestige Wealth Management Group held 18 shares of ResMed worth $3.51K as of Q2 2026.
Prestige Wealth Management Group bought 4 ResMed shares in Q2 2026, an estimated $829.
ResMed made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #658 holding.
Prestige Wealth Management Group first reported a position in ResMed in Q4 2018 and has held it in 27 quarters since.
Prestige Wealth Management Group's ResMed position peaked at $3.83K in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.